Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001011438-25-000126
Filing Date
2025-02-13
Accepted
2025-02-13 18:23:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9275
  Complete submission text file 0001011438-25-000126.txt   11255
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Subject) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-85385 | Film No.: 25622191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 535 MADISON AVENUE, 36TH FLOOR NEW YORK NY 10022
Business Address 535 MADISON AVENUE, 36TH FLOOR NEW YORK NY 10022 212-792-8800
CADIAN CAPITAL MANAGEMENT, LP (Filed by) CIK: 0001423686 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A